Total planned funding: $539,998,540
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $539,998,540 |
Organizational Types
NGO | $141,844,465 |
Private Contractor | $121,404,646 |
Host Country Government Agency | $79,876,631 |
Own Agency | $74,523,293 |
University | $45,659,522 |
Unknown | $44,250,028 |
Parastatal | $10,463,592 |
Implementing Agency | $7,949,070 |
Other USG Agency | $6,833,490 |
FBO | $4,170,045 |
Multi-lateral Agency | $3,023,758 |
Program Areas
Treatment | $144,523,108 |
Prevention | $116,341,387 |
Care | $109,464,641 |
Governance and Systems | $74,823,113 |
Management and Operations | $54,953,837 |
Testing | $39,892,454 |
Budget Codes
HTXS: Treatment: Adult Treatment | $114,385,198 |
HVMS: Management and Operations | $54,953,837 |
HKID: Care: Orphans and Vulnerable Children | $41,130,237 |
HVCT: Testing: HIV Testing and Counseling | $39,892,454 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $39,442,722 |
HBHC: Care: Adult Care and Support | $39,392,032 |
OHSS: Health Systems Strengthening | $37,395,814 |
HVOP: Sexual Prevention: Other Sexual Prevention | $28,539,385 |
HVSI: Strategic Information | $27,941,475 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $21,812,451 |
HVTB: Care: TB/HIV | $19,352,808 |
HTXD: Treatment: ARV Drugs | $18,147,214 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $18,031,915 |
PDTX: Treatment: Pediatric Treatment | $11,990,696 |
PDCS: Care: Pediatric Care and Support | $9,589,564 |
HLAB: Laboratory Infrastructure | $9,485,824 |
HMBL: Biomedical Prevention: Blood Safety | $5,457,458 |
HMIN: Biomedical Prevention: Injection Safety | $3,057,456 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$67,690,866
Countries/Regions
USG Aggregated Agencies:
$44,848,948
Countries/Regions
Not Available:
$37,314,301
Countries/Regions